Intramedullary Melanocytoma with Multifocal Spinal Recurrence: An Uncommon Case Study - Report - MDSpire

Intramedullary Melanocytoma with Multifocal Spinal Recurrence: An Uncommon Case Study

  • By

  • Jiri Nepozitek

  • Veronika Rottova

  • Martin Syrucek

  • Veronika Ticha

  • January 5, 2026

  • 0 min

Share

Clinical Report: Intramedullary Melanocytoma with Multifocal Spinal Recurrence

Overview

This report presents a rare case of intramedullary melanocytoma recurrence with multifocal extramedullary lesions. The patient experienced significant neurological deterioration due to extensive spinal cord compression, highlighting the aggressive nature of this tumor despite its benign histological features.

Background

Intramedullary melanocytomas are exceedingly rare tumors of the central nervous system, with fewer than 30 cases documented globally. Although classified as benign, they often exhibit locally aggressive behavior and a tendency for recurrence, particularly in the spinal axis. Understanding their clinical behavior is crucial for effective management and treatment planning.

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

  • Intramedullary melanocytomas are rare, with fewer than 30 cases reported worldwide.
  • These tumors can demonstrate locally aggressive behavior despite benign histological characteristics.
  • Recurrence can manifest as multifocal extramedullary lesions, leading to significant neurological deficits.
  • The case presented involved a 70-year-old woman with severe paraparesis and extensive spinal cord compression due to recurrence.
  • Histopathological examination confirmed the diagnosis with specific immunohistochemical markers.

Clinical Implications

Management of intramedullary melanocytomas requires careful consideration of the tumor's aggressive potential and the risks associated with surgical intervention. Palliative care and rehabilitation may be necessary for patients with extensive recurrence, as radical resection may not be feasible.

Conclusion

This case underscores the need for ongoing surveillance and a multidisciplinary approach in managing intramedullary melanocytomas, particularly in light of their potential for multifocal recurrence and associated complications.

References

  1. Journal of Neuro-Oncology, 2025 -- Differentiating Between Benign and Malignant: Insights into Spinal Melanocytomas and Their Relation to Melanoma
  2. Journal of Neuro-Oncology, 2010 -- Emergence of Neurometastatic Merkel Cell Carcinoma: A Case Series and Review of Existing Literature
  3. Case Series and Systematic Review of Metastatic Meningioma, 2023
  4. Progress in Multidisciplinary Surgical Strategies for Primary Spinal Sarcomas, 2024
  5. Major Features of the 2021 WHO Classification of CNS Tumors - PMC
  6. Primary Intramedullary Spinal Melanocytomas: Case Report and Review of Clinical Features, Diagnosis, and Management
  7. Major Features of the 2021 WHO Classification of CNS Tumors - PMC
  8. Primary Intramedullary Spinal Melanocytomas: Case Report and Review of Clinical Features, Diagnosis, and Management

Original Source(s)

Related Content